Feasibility of improving platelet‑rich plasma therapy by using chitosan with high platelet activation ability

Hattori,Hidemi; Ishihara,Masayuki

doi:10.3892/etm.2017.4041

Feasibility of improving platelet‑rich plasma therapy by using chitosan with high platelet activation ability

Authors:
- Hidemi Hattori
- Masayuki Ishihara
View Affiliations

Affiliations: Division of Biomedical Engineering, Research Institute, National Defense Medical College, Tokorozawa, Saitama 359‑8513, Japan
Published online on: January 13, 2017 https://doi.org/10.3892/etm.2017.4041
Pages: 1176-1180

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Platelet-rich plasma (PRP) is blood plasma containing a high number of platelets that release growth factors for wound healing and tissue regeneration. In the present study, the feasibility of improving PRP therapy by using chitosan that exhibits high platelet activation ability was investigated. A total of 13 chitosan samples with different molecular weight (Mw) and degree of deacetylation (DDA) were individually added to blood samples of rats and the amount of growth factors, albumin and fibrinogen in plasma was measured. To examine the influence of plasma activated by chitosan on the proliferation of fibroblasts and adipose tissue‑derived stromal cells (ASCs), the plasma was added to the culture medium of human fibroblasts and adipose tissue‑derived stromal cells. Chitosan with a DDA of >75% increased the release of platelet factor 4 into the plasma. The amount of growth factors released into the plasma and platelet activation varied depending on the Mw and DDA, while albumin and fibrinogen were hardly affected. The proliferation rate was highest when using plasma activated by chitosan with a DDA of 75‑85% and an Mw of 50,000‑190,000 Da. These results suggested that the effectiveness of PRP therapy may be improved by using chitosan with a DDA of 75‑85% and an Mw of 50,000‑190,000 Da.

View Figures

View References

1	Ferrari M, Zia S, Valbonesi M, Henriquet F, Venere G, Spagnolo S, Grasso MA and Panzani I: A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs. 10:47–50. 1987.PubMed/NCBI
2	Greer N, Foman NA, MacDonald R, Dorrian J, Fitzgerald P, Rutks I and Wilt TJ: Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers: A systematic review. Ann Intern Med. 159:532–542. 2013. View Article : Google Scholar : PubMed/NCBI
3	Jones KR, Fennie K and Lenihan A: Evidence-based management of chronic wounds. Adv Skin Wound Care. 20:591–600. 2007. View Article : Google Scholar : PubMed/NCBI
4	Carter MJ, Fylling CP and Parnell LK: Use of platelet rich plasma gel on wound healing: A systematic review and meta-analysis. Eplasty. 11:e382011.PubMed/NCBI
5	Steed DL, Attinger C, Colaizzi T, Crossland M, Franz M, Harkless L, Johnson A, Moosa H, Robson M, Serena T, et al: Guidelines for the treatment of diabetic ulcers. Wound Repair Regen. 14:680–692. 2006. View Article : Google Scholar : PubMed/NCBI
6	Bolton LL, van Rijswijk L and Shaffer FA: Quality wound care equals cost-effective wound care: A clinical model. Adv Wound Care. 10:33–38. 1997.PubMed/NCBI
7	Zucker MB and Nachmias VT: Platelet activation. Arteriosclerosis. 5:2–18. 1985. View Article : Google Scholar : PubMed/NCBI
8	Winokur R and Hartwig JH: Mechanism of shape change in chilled human platelets. Blood. 85:1796–1804. 1995.PubMed/NCBI
9	Kroll MH, Hellums JD, McIntire LV, Schafer AI and Moake JL: Platelets and shear stress. Blood. 88:1525–1541. 1996.PubMed/NCBI
10	Brown GT, Narayanan P, Li W, Silverstein RL and McIntyre TM: Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop. J Immunol. 191:5196–5203. 2013. View Article : Google Scholar : PubMed/NCBI
11	Li Z, Delaney MK, O'Brien KA and Du X: Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol. 30:2341–2349. 2010. View Article : Google Scholar : PubMed/NCBI
12	Kowalska MA, Rauova L and Poncz M: Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. Thromb Res. 125:292–296. 2010. View Article : Google Scholar : PubMed/NCBI
13	Burnouf T, Goubran HA, Chen TM, Ou KL, El-Ekiaby M and Radosevic M: Blood-derived biomaterials and platelet growth factors in regenerative medicine. Blood Rev. 27:77–89. 2013. View Article : Google Scholar : PubMed/NCBI
14	Nakamura T, Teramoto H and Ichihara A: Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary culture. Proc Natl Acad Sci USA. 83:6489–6493. 1986. View Article : Google Scholar : PubMed/NCBI
15	Hattori H, Amano Y, Nogami Y, Takase B and Ishihara M: Hemostasis for severe hemorrhage with photocrosslinkable chitosan hydrogel and calcium alginate. Ann Biomed Eng. 38:3724–3732. 2010. View Article : Google Scholar : PubMed/NCBI
16	Ono K, Ishihara M, Ozeki Y, Deguchi H, Sato M, Saito Y, Yura H, Sato M, Kikuchi M, Kurita A and Maehara T: Experimental evaluation of photocrosslinkable chitosan as a biologic adhesive with surgical applications. Surgery. 130:844–850. 2001. View Article : Google Scholar : PubMed/NCBI
17	Wedmore I, McManus JG, Pusateri AE and Holcomb JB: A special report on the chitosan-based hemostatic dressing: Experience in current combat operations. J Trauma. 60:655–658. 2006. View Article : Google Scholar : PubMed/NCBI
18	Sarasam AR, Brown P, Khajotia SS, Dmytryk JJ and Madihally SV: Antibacterial activity of chitosan-based matrices on oral pathogens. J Mater Sci Mater Med. 19:1083–1090. 2008. View Article : Google Scholar : PubMed/NCBI
19	Mellegard H, Kovács ÁT, Lindbäck T, Christensen BE, Kuipers OP and Granum PE: Transcriptional responses of Bacillus cereus towards challenges with the polysaccharide chitosan. PLoS One. 6:e243042011. View Article : Google Scholar : PubMed/NCBI
20	Shigemasa Y and Minami S: Applications of chitin and chitosan for biomaterials. Biotechnol Genet Eng Rev. 13:383–420. 1996. View Article : Google Scholar : PubMed/NCBI
21	Park CJ, Gabrielson NP, Pack DW, Jamison RD and Johnson AJ Wagoner: The effect of chitosan on the migration of neutrophil-like HL60 cells, mediated by IL-8. Biomaterials. 30:436–444. 2009. View Article : Google Scholar : PubMed/NCBI
22	Hattori H and Ishihara M: Changes in blood aggregation with differences in molecular weight and degree of deacetylation of chitosan. Biomed Mater. 10:0150142015. View Article : Google Scholar : PubMed/NCBI
23	Kutlu B, Tiğlı Aydın RS, Akman AC, Gümüşderelioglu M and Nohutcu RM: Platelet-rich plasma-loaded chitosan scaffolds: Preparation and growth factor release kinetics. J Biomed Mater Res B Appl Biomater. 101:28–35. 2013. View Article : Google Scholar : PubMed/NCBI
24	Busilacchi A, Gigante A, Mattioli-Belmonte M, Manzotti S and Muzzarelli RA: Chitosan stabilizes platelet growth factors and modulates stem cell differentiation toward tissue regeneration. Carbohydr Polym. 98:665–676. 2013. View Article : Google Scholar : PubMed/NCBI
25	Oktay EO, Demiralp B, Demiralp B, Senel S, Akman A Cevdet, Eratalay K and Akincibay H: Effects of platelet-rich plasma and chitosan combination on bone regeneration in experimental rabbit cranial defects. J Oral Implantol. 36:175–184. 2010. View Article : Google Scholar : PubMed/NCBI
26	Bosmann HB: Platelet adhesiveness and aggregation: II. Surface sialic acid, glycoprotein: N-acetylneuraminic acid transferase, and neuraminidase of human blood platelets. Biochim Biophys Acta. 279:456–474. 1972. View Article : Google Scholar : PubMed/NCBI
27	Lupu C and Calb M: Changes in the platelet surface charge in rabbits with experimental hypercholesterolemia. Atherosclerosis. 72:77–82. 1988. View Article : Google Scholar : PubMed/NCBI
28	vd Winkel JG, Wetzels JF, van Duijnhoven JL, Koene RA and Capel PJ: Red blood cell surface charge and alcian blue binding. Nephrol Dial Transplant. 2:280–281. 1987.PubMed/NCBI
29	Briedé JJ, Heemskerk JW, Hemker HC and Lindhout T: Heterogeneity in microparticle formation and exposure of anionic phospholipids at the plasma membrane of single adherent platelets. Biochim Biophys Acta. 1451:163–172. 1999. View Article : Google Scholar : PubMed/NCBI
30	Mackman N, Tilly RE and Key NS: Role of the extinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 27:1687–1693. 2007. View Article : Google Scholar : PubMed/NCBI
31	McEver RP: Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost. 86:746–756. 2001.PubMed/NCBI
32	Klinger MH: Platelets and inflammation. Anat Embryol (Berl). 196:1–11. 1997. View Article : Google Scholar : PubMed/NCBI
33	Hagberg IA and Lyberg T: Evaluation of circulating platelet-leukocyte conjugates: A sensitive flow cytometric assay well suited for clinical studies. Platelets. 11:151–160. 2000. View Article : Google Scholar : PubMed/NCBI
34	Shen EC, Chou TC, Gau CH, Tu HP, Chen YT and Fu E: Releasing growth factors from activated human platelets after chitosan stimulation: A possible bio-material for platelet-rich plasma preparation. Clin Oral Implants Res. 17:572–578. 2006. View Article : Google Scholar : PubMed/NCBI
35	Fukusawa M, Abe H, Masaoka T, Orita H, Horikawa H, Campeau JD and Washio M: The hemostatic effect of deacetylated chitin membrane on peritoneal injury in rabbit model. Surg Today. 22:333–338. 1992. View Article : Google Scholar : PubMed/NCBI
36	International committee for standardization in hematology, . Recommendation of measurement of erythrocyte sedimentation rate of human blood. Am J Clin Pathol. 68:505–507. 1977. View Article : Google Scholar : PubMed/NCBI
37	Sugamori T, Iwase H, Maeda M, Inoue Y and Kurosawa H: Local hemostatic effects of microcrystalline partially deacetylated chitin hydrochloride. J Biomed Mater Res. 49:225–232. 2000. View Article : Google Scholar : PubMed/NCBI
38	Lubkowska A, Dolegowska B and Banfi G: Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents. 26(2): Suppl 1. S3–S22. 2012.
39	Miyazawa K: Hepatocyte growth factor activator (HGFA): A serine protease that links tissue injury to activation of hepatocyte growth factor. FEBS. 277:2208–2214. 2010. View Article : Google Scholar
40	Han J, Meng HX, Tang JM, Li SL, Tang Y and Chen ZB: The effect of different platelet-rich plasma concentrations on proliferation and differentiation of human periodontal ligament cells in vitro. Cell Prolif. 40:241–252. 2007. View Article : Google Scholar : PubMed/NCBI
41	Bura A, Planat-Benard V, Bourin P, Silvestre JS, Gross F, Grolleau JL, Saint-Lebese B, Peyrafitte JA, Fleury S, Gadelorge M, et al: Phase I trial: The use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy. 16:245–257. 2014. View Article : Google Scholar : PubMed/NCBI
42	He Q, Ao Q, Gong K, Zhang L, Hu M, Gong Y and Zhang X: Preparation and characterization of chitosan-heparin composite matrices for blood contacting tissue engineering. Biomed Mater. 5:0550012010. View Article : Google Scholar : PubMed/NCBI
43	Busher JT: Serum albumin and globulinClinical Methods: The History, Physical and Laboratory Examinations. Walker KH, Hall DW and Hurst WJ: 3rd. Butterworth Publishers; Boston: pp. 497–499. 1990